Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease

Sunny, Nishanth E., Parks, Elizabeth J., Browning, Jeffrey D., Burgess, Shawn C.·2011·Cell Metabolism

Cited by (683)

Items 301–400 of 683

  1. Fatty liver disrupts glycerol metabolism in gluconeogenic and lipogenic pathways in humans
    Eunsook S. Jin, Jeffrey D. Browning, Rebecca E. Murphy, Craig R. Malloy · 2018 · Journal of Lipid Research
  2. Acyl‐Coenzyme A Thioesterase 9 Traffics Mitochondrial Short‐Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver
    Sandra Steensels, Jixuan Qiao, Yanzhen Zhang, Kristal M. Maner-Smith, NOURHAN KIKA, Corey D. Holman, Kathleen E. Corey, William Clay Bracken, Eric A. Ortlund, Baran A. Ersoy · 2020 · Hepatology
  3. Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative Stress
    Christiane Rennert, Theresa Heil, Gerda Schicht, Anna Stilkerich, Lena Seidemann, Victoria Kegel, Daniel Seehofer, Georg Damm · 2020 · International Journal of Molecular Sciences
  4. Mediators and clinical treatment for cancer cachexia: a systematic review
    Zhipeng Cao, Andrew Mark Scott, Nick J. Hoogenraad, Laura Danielle Osellame · 2021 · JCSM Rapid Communications
  5. Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver
    Fu, Xiaorong, Fletcher, Justin A., Deja, Stanisław, Inigo-Vollmer, Melissa, Burgess, Shawn C., Browning, Jeffrey D. · 2023 · Journal of Clinical Investigation
  6. Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
    Stefano Gitto, Giovanni Vitale, Erica Villa, Pietro Andreoné · 2015 · Gastroenterology Research and Practice
  7. A Metabonomics Approach to Drug Toxicology in Liver Disease and its Application in Traditional Chinese Medicine
    Guangyue Su, Haifeng Wang, Jiao Bai, Gang Chen, Yue‐Hu Pei · 2019 · Current Drug Metabolism
  8. Energy disorders caused by mitochondrial dysfunction contribute to α-amatoxin-induced liver function damage and liver failure
    Xiao Chen, Bing Shao, Chengmin Yu, Qunmei Yao, Ma Peibin, Weiwei Li, Bin Li, Chengye Sun · 2020 · Toxicology Letters
  9. Exercise prevents fatty liver by modifying the compensatory response of mitochondrial metabolism to excess substrate availability
    Miriam Hoene, Lisa Kappler, Laxmikanth Kollipara, Chunxiu Hu, Martin Irmler, Daniel Bleher, Christoph Hoffmann, Johannes Beckers, Martin Hrabě de Angelis, Hans‐Ulrich Häring et al. · 2021 · Molecular Metabolism
  10. Inulin activates FXR-FGF15 signaling and further increases bile acids excretion in non-alcoholic fatty liver disease mice
    Rui Wang, Yi Ren, Ting Bao, Ting Wang, Yiwei Li, Yuanyuan Liu, Xiaoxia Zhang, Shaoqi Yang, Hao Wang · 2022 · Biochemical and Biophysical Research Communications
  11. Targeting skeletal muscle mitochondria to prevent type 2 diabetes in youth
    Joseph W. Gordon, Vernon Wayne Dolinsky, Wajihah Mughal, Grant Robert Gordon, Jonathan McGavock · 2015 · Biochemistry and Cell Biology
  12. Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver Disease
    Haoyong Yu, Weiping Jia, ZengKui Guo · 2014 · Journal of Clinical Medicine
  13. Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
    Manuela Vitulo, Elisa Gnodi, Giulia Rosini, Raffaella Meneveri, Roberto Giovannoni, Donatella Barisani · 2023 · International Journal of Molecular Sciences
  14. Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis
    Yingchun Wang, Wei-Zong Kong, Qing-Mei Jin, Juan Chen, Lei Dong · 2015 · World Journal of Gastroenterology
  15. Impact of Sodium Glucose Cotransporter 2 Inhibitors on Nonalcoholic Fatty Liver Disease Complicated by Diabetes Mellitus
    Enxiang Zhang, Yang Zhao, Hongbo Hu · 2021 · Hepatology Communications
  16. Pyruvate Carboxylase Wields a Double-Edged Metabolic Sword
    Curtis C. Hughey, Peter A. Crawford · 2019 · Cell Metabolism
  17. Improvement of the hepatic lipid status in intrauterine growth retarded pigs by resveratrol is related to the inhibition of mitochondrial dysfunction, oxidative stress and inflammation
    Kang Cheng, Peilu Jia, Shuli Ji, Zhihua Song, Hao Zhang, Lili Zhang, Tian Z. Wang · 2020 · Food & Function
  18. Pgc-1α controls epidermal stem cell fate and skin repair by sustaining NAD+ homeostasis during aging
    Wesley Wong, Elizabeth D. Crane, Hui Zhang, Jiahe Li, Tovah A. Day, Alex E. Green, Keir J. Menzies, Justin D. Crane · 2022 · Molecular Metabolism
  19. The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease
    Huanzhuo Mai, Xing Hua Yang, Yulan Xie, Jie Zhou, Qing Wang, Yiru Wei, Yuecong Yang, Dongjia Lu, Li Ye, Ping Cui et al. · 2024 · Frontiers in Microbiology
  20. Ketone body metabolism and cardiometabolic implications for cognitive health
    Kyle Fulghum, Sebastian F. Salathe, Xin C. Davis, John P. Thyfault, Patrycja Puchalska, Peter A. Crawford · 2024 · npj Metabolic Health and Disease
  21. Ketogenesis supports hepatic polyunsaturated fatty acid homeostasis via fatty acid elongation
    Queathem, Eric D., Moazzami, Zahra, Stagg, David B., Nelson, Alisa B., Fulghum, Kyle, Hayir, Abdirahman, Seay, Alisha, Gillingham, Jacob R., d’Avignon, D. André, Han, Xianlin et al. · 2025 · Science Advances
  22. Model‐Based Assessment of Plasma Citrate Flux Into the Liver: Implications for NaCT as a Therapeutic Target
    Z Li, Derek M. Erion, Tristan S. Maurer · 2016 · CPT Pharmacometrics & Systems Pharmacology
  23. Luteolin ameliorates palmitate-induced lipotoxicity in hepatocytes by mediating endoplasmic reticulum stress and autophagy
    Chun‐Yin Huang, Haw‐Wen Chen, Chia‐Wen Lo, Yu-Ru Wang, Chien‐Chun Li, Kai‐Li Liu, Chong‐Kuei Lii · 2022 · Food and Chemical Toxicology
  24. The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the 13 C-ketoisocaproate breath test
    Paul R. Afolabi, Eleonora Scorletti, Debbie E. Smith, Amal Almehmadi, Philip C. Calder, Christopher D. Byrne · 2018 · Journal of Breath Research
  25. The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development
    Rory P. Cunningham, Ryan D. Sheldon, R. Scott Rector · 2020 · Frontiers in Physiology
  26. Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD)
    Ignazio Grattagliano, Agostino Di Ciaula, Jacek Baj, Emilio Molina‐Molina, Harshitha Shanmugam, Gabriella Garruti, David Q.‐H. Wang, Piero Portincasa · 2021 · Methods in molecular biology
  27. From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria
    Ricardo Amorim, Carina C. Magalhães, Fernanda Borges, Paulo Jorge Oliveira, José Teixeira · 2023 · Biology
  28. Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice
    Esther Nuñez‐Durán, Belén Chanclón, Silva Sütt, Joana I. Real, Hanns–Ulrich Marschall, Ingrid Wernstedt Asterholm, Emmelie Cansby, Margit Mahlapuu · 2017 · Journal of Endocrinology
  29. Hepatic fat is a stronger correlate of key clinical and molecular abnormalities than visceral and abdominal subcutaneous fat in youth
    Catherine E. Cioffi, K.M. Venkat Narayan, Ken Liu, Karan Uppal, Dean P. Jones, ViLinh Tran, Tianwei Yu, Jessica A. Alvarez, Moriah P. Bellissimo, Kristal M. Maner-Smith et al. · 2020 · BMJ Open Diabetes Research & Care
  30. Glutamate–Serine–Glycine Index: A Novel Potential Biomarker in Pediatric Non-Alcoholic Fatty Liver Disease
    Simone Leonetti, Raimund I. Herzog, Sonia Caprio, Nicola Santoro, Domenico Tricò · 2020 · Children
  31. Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
    Ji‐Yeon Lee, Young‐Eun Kim, Kyungdo Han, Eugene Han, Byung‐Wan Lee, Eun Seok Kang, Bong Soo, Seung‐Hyun Ko, Yong‐ho Lee · 2022 · JAMA Network Open
  32. Role of Insulin Resistance and Diabetes in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
    Paola Portillo-Sánchez, Sahzene Yavuz, Fernando Bril, Kenneth J. Cusi · 2014 · Current Hepatology Reports
  33. SmD3 Regulates Intronic Noncoding RNA Biogenesis
    Benjamin S. Scruggs, Carlos I. Michel, Daniel S. Ory, Jean E. Schaffer · 2012 · Molecular and Cellular Biology
  34. Intrinsic High Aerobic Capacity in Male Rats Protects Against Diet-Induced Insulin Resistance
    E. Matthew Morris, Grace Margaret-Eleanor Meers, Gregory N. Ruegsegger, Umesh D. Wankhade, Tommy Robinson, Lauren G. Koch, Steven L. Britton, R. Scott Rector, Kartik Shankar, John P. Thyfault · 2019 · Endocrinology
  35. Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease
    Inês C. M. Simões, J. Janikiewicz, J. Bauer, A. Karkucińska-Więckowska, P. Kalinowski, A. Dobrzyń, A. Wolski, M. Pronicki, K. Zieniewicz, P. Dobrzyn et al. · 2019 · Nutrients
  36. In-vitro and in-vivo evaluation of the molecular mechanisms involved in the toxicity associated to CdSe/ZnS quantum dots exposure
    Estefanía García‐Calvo, Pablo Cabezas-Sánchez, Jose Luis Luque-Garcia · 2020 · Chemosphere
  37. Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing
    Mengjuan Gong, Cai-Yan Zhu, Zhongjie Zou, Bin Han, Ping Huang · 2021 · Journal of Pharmaceutical and Biomedical Analysis
  38. Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides
    Leinys S. Santos Baez, Henry N. Ginsberg · 2021 · Current Opinion in Lipidology
  39. Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease
    Liangliang Zhou, Hai-Yuan Shen, Xiao-Feng Li, Hua Wang · 2022 · Frontiers in Immunology
  40. Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated by Diabetes: Pathophysiology and Emerging Therapies
    Hisanori Goto, Toshinari Takamura · 2025 · Journal of Obesity & Metabolic Syndrome
  41. The Impact and Burden of Dietary Sugars on the Liver
    Helaina E. Huneault, Ana Ramirez Tovar, Cristian Sanchez-Torres, Jean A. Welsh, Miriam B. Vos · 2023 · Hepatology Communications
  42. The presence of the ovary prevents hepatic mitochondrial oxidative stress in young and aged female mice through glutathione peroxidase 1
    Ana P. Valencia, Anna E. Schappal, E. Matthew Morris, John P. Thyfault, Dawn A. Lowe, Espen E. Spangenburg · 2015 · Experimental Gerontology
  43. Korean Pine Nut Oil Attenuated Hepatic Triacylglycerol Accumulation in High-Fat Diet-Induced Obese Mice
    So‐Young Park, Sunhye Shin, Yeseo Lim, Jae Shin, Je Kyung Seong, Sung Nim Han · 2016 · Nutrients
  44. Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling
    Kevin C. Corbit, João Paulo Camporez, Lia R. Edmunds, Jennifer L. Tran, Nicholas B. Vera, Derek M. Erion, Rahul C. Deo, Rachel J. Perry, Gerald I. Shulman, Michael J. Jurczak et al. · 2017 · Diabetes
  45. Cannabis sativa L. (var. indica) Exhibits Hepatoprotective Effects by Modulating Hepatic Lipid Profile and Mitigating Gluconeogenesis and Cholinergic Dysfunction in Oxidative Hepatic Injury
    Ochuko Lucky Erukainure, Motlalepula Gilbert Matsabisa, Veronica F. Salau, Sunday Oyewole Oyedemi, Omolola Rebecca Oyenihi, Collins U. Ibeji, Md. Shahidul Islam · 2021 · Frontiers in Pharmacology
  46. Independent association of liver fat accumulation with insulin resistance
    Hiroshi Yatsuya, Takashi Nihashi, Yuanying Li, Yo Hotta, Kunihiro Matsushita, Takashi Muramatsu, Rei Otsuka, Masaaki Matsunaga, Kentaro Yamashita, Chaochen Wang et al. · 2013 · Obesity Research & Clinical Practice
  47. VCD-induced menopause mouse model reveals reprogramming of hepatic metabolism
    Roshan Kumari, Michael E. Ponte, Edziu Franczak, John C. Prom, Maura F. O’Neil, Mihaela E. Sardiu, Andrew J. Lutkewitte, Lane K. Christenson, Kartik Shankar, E. Matthew Morris et al. · 2024 · Molecular Metabolism
  48. Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease
    Eiji Kakazu, Masaaki Mino, Tatsuya Kanto · 2025 · Clinical and Molecular Hepatology
  49. Q-Flux: A method to assess hepatic mitochondrial succinate dehydrogenase, methylmalonyl-CoA mutase, and glutaminase fluxes in vivo
    Brandon T. Hubbard, Traci E. LaMoia, Leigh Goedeke, Rafael Calais Gaspar, Katrine Douglas Galsgaard, Mario Kahn, Graeme F. Mason, Gerald I. Shulman · 2022 · Cell Metabolism
  50. The emerging significance of mitochondrial targeted strategies in NAFLD treatment
    Tao Zhang, Yingli Nie, Jiliang Wang · 2023 · Life Sciences
  51. Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk
    Felix Westcott, David Dearlove, Leanne Hodson · 2023 · Atherosclerosis
  52. Shining LIGHT on the metabolic role of the cytokine TNFSF 14 and the implications on hepatic IL ‐6 production
    Bernadette M. Saunders, Caroline Rudnicka, Aleksandra Filipovska, Stefan M.K. Davies, Natalie C. Ward, Jana Hricová, Markus Peter Schlaich, Vance Bruce Matthews · 2017 · Immunology and Cell Biology
  53. β2-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states
    Yun Shi, Jason D. Pizzini, Hanzhou Wang, Falguni Das, Parveez Ahamed Abdul Azees, Goutam Ghosh Choudhury, Jeffrey L. Barnes, Mengwei Zang, Susan T. Weintraub, Chih‐Ko Yeh et al. · 2021 · American Journal of Physiology-Endocrinology and Metabolism
  54. A Lard and Soybean Oil Mixture Alleviates Low-Fat–High-Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease in Mice
    Sisi Yan, Sha Liu, Jianyu Qu, Xiaowen Li, Jiahao Hu, Linyu Zhang, Xiangyan Liu, Xin Li, Xianglin Wang, Lixin Wen et al. · 2022 · Nutrients
  55. Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression
    Natasha A. Trzaskalski, Branka Vulesevic, My-Anh Nguyen, Natasha Jeraj, Evgenia Fadzeyeva, Nadya M. Morrow, Cassandra A.A. Locatelli, Nicole Travis, Antonio A. Hanson, Julia R.C. Nunes et al. · 2022 · JCI Insight
  56. Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention
    Yaodi Shao, Suzhen Chen, Han Liu, Junli Liu · 2023 · Nutrition & Metabolism
  57. Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study
    Jian Zhao, Jing Zeng, Cairong Zhu, Xuechao Li, Dong Liu, Jun Zhang, Fei Li, Giovanni Targher, Jian‐Gao Fan · 2023 · BMC Medicine
  58. Intracellular lipid accumulation and shift during diabetes progression
    Peter S. Wolf, Yvonne Winhofer, Christian Heinz Anderwald, Martin Krššák, Michael Krebs · 2014 · Wiener Medizinische Wochenschrift
  59. Obesity and Exercise: New Insights and Perspectives
    James, Natasha Maria, Stanford, Kristin I · 2025 · Endocrine Reviews
  60. Dual Role of Pregnane X Receptor in Nonalcoholic Fatty Liver Disease
    Yuan Xu, Ziming An, Shufei Wang, Yiming Ni, Mingmei Zhou, Qin Feng, Xiaojun Gou, Meiling Xu, Ying Qi · 2023 · Current Molecular Pharmacology
  61. Hepatic Mediators of Lipid Metabolism and Ketogenesis: Focus on Fatty Liver and Diabetes
    Gustavo Werpel Fernandes, Bárbara M. L. C. Bocco · 2020 · Current Diabetes Reviews
  62. Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice
    Ji Eun Kim, Ji Yeon Lee, Chang-Ho Kang · 2022 · Foods
  63. Integration of transcriptomics and metabonomics revealed the protective effects of hemp seed oil against methionine–choline-deficient diet-induced non-alcoholic steatohepatitis in mice
    Mengjuan Gong, Hailong Lu, Lixi Li, Meiqi Feng, Zhongjie Zou · 2023 · Food & Function
  64. Comprehensive isotopomer analysis of glutamate and aspartate in small tissue samples
    Feng Cai, Divya Bezwada, Ling Cai, Rohit Mahar, Zheng Wu, Mario C. Chang, Panayotis Pachnis, Chendong Yang, Sherwin Kelekar, Wen Gu et al. · 2023 · Cell Metabolism
  65. Systematic Analysis of the Gene Expression in the Livers of Nonalcoholic Steatohepatitis: Implications on Potential Biomarkers and Molecular Pathological Mechanism
    Yida Zhang, Susan S. Baker, Robert D. Baker, Ruixin Zhu, Lixin Zhu · 2012 · PLoS ONE
  66. Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function
    Kelley Núñez, Paul Thevenot, Abeer Alfadhli, Ari J. Cohen · 2018 · International Journal of Molecular Sciences
  67. Roux‐en‐Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission
    Laurentiu M. Pop, Andrea Mari, Tong‐Jin Zhao, Lori Mitchell, Shawn C. Burgess, Xilong Li, BEVERLEY A. ADAMS-HUET, Ildiko Lingvay · 2018 · Diabetes Obesity and Metabolism
  68. LC-MS-Based Metabolomic Study of Oleanolic Acid-Induced Hepatotoxicity in Mice
    Feng Hong, Ying-Qiu Wu, Ya-Sha Xu, Kexin Wang, Xuemei Qin, Yuan‐Fu Lu · 2020 · Frontiers in Pharmacology
  69. Ketogenesis mitigates metabolic dysfunction–associated steatotic liver disease through mechanisms that extend beyond fat oxidation
    Eric D. Queathem, David B. Stagg, Alisa B. Nelson, Alec Chaves, Scott B. Crown, Kyle Fulghum, D. André d’Avignon, Justin R. Ryder, Patrick J. Bolan, Abdirahman Hayir et al. · 2025 · Journal of Clinical Investigation
  70. Hepatic Mitochondrial Oxidative Metabolism and Lipogenesis Synergistically Adapt to Mediate Healthy Embryonic-to-Neonatal Transition in Chicken
    Chaitra Surugihalli, Tom E. Porter, Angela Chan, Linda S. Farley, Meghan Maguire, Christine Zhang, Nathan Kattapuram, Muhammed Shafeekh Muyyarikkandy, Hsiao‐Ching Liu, Nishanth E. Sunny · 2019 · Scientific Reports
  71. Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver
    Ariel Vivero, Manuel Ruz O, Matías Rivera, Karen Miranda, Camila Sacristán, Alejandra Espinosa, Juana Codoceo, Jorge Inostroza, Karla Yohannessen Vásquez, Álvaro Pérez et al. · 2020 · Biological Trace Element Research
  72. Tartary buckwheat (Fagopyrum tataricum (L.) Gaertn) protein-derived antioxidant peptides: mechanisms of action and structure-activity relationship in Caco-2 cell models
    Yiming Zhou, Xuanming She, Zhidong Chen, Yun Lin Wei, Ying Xiao, Xiaoli Zhou · 2022 · Food Science and Human Wellness
  73. Glial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expression
    Simon Musyoka Mwangi, Sophia Peng, Behtash Ghazi Nezami, Natalie E. Thorn, Alton B. Farris, Sanjay R. Jain, Hamed Laroui, Didier Merlin, Frank A. Anania, Shanthi Srinivasan · 2015 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  74. Copper modulates sex-specific fructose hepatoxicity in nonalcoholic fatty liver disease (NALFD) Wistar rat models
    Austin Morrell, Brian Tripet, Brian J. Eilers, Megan Tegman, Damon Thompson, Valérie Copié, Jason L. Burkhead · 2019 · The Journal of Nutritional Biochemistry
  75. Vitamin E does not prevent Western diet-induced NASH progression and increases metabolic flux dysregulation in mice
    Clinton M. Hasenour, Arion J. Kennedy, T. Bednarski, Irina A. Trenary, Brandon James Eudy, Robin Paul da Silva, Kelli Lynn Boyd, Jamey D. Young · 2020 · Journal of Lipid Research
  76. Stable isotope-based flux studies in nonalcoholic fatty liver disease
    Arthur J. McCullough, Stephen F. Previs, Takhar Kasumov · 2017 · Pharmacology & Therapeutics
  77. Skeletal muscle mitochondrial dysfunction is associated with increased Gdf15 expression and circulating GDF15 levels in aged mice
    J. Chen, JAKE KASTROLL, Fiona M. Bello, Martha M. Pangburn, A. Murali, P. M. Smith, K. Rychcik, Kelly E. Loughridge, Amber M. Vandevender, Nikolaos L. Dedousis et al. · 2025 · Scientific Reports
  78. Phosphoenolpyruvate carboxykinase 1-mediated cataplerosis is required to maintain mitochondrial fitness and to avoid kidney disease progression
    Delal Dalga, Anna Maria Rinaldi, Xiaorong Fu, Lucie Chanvillard, Aurélie Huber, Anna Faivre, David Antoine Jaques, Lena Berchtold, Julien Boccard, Grégoire Arnoux et al. · 2025 · Kidney International
  79. Hepatic Gadd45β promotes hyperglycemia and glucose intolerance through DNA demethylation of PGC-1α
    Ling Wu, Yang Jiao, Yao Li, Jingjing Jiang, Lin Zhao, Menghui Li, Bin Li, Zheng Yan, Xue-Jin Chen, Xiao-Ying Li et al. · 2021 · Journal of Experimental Medicine
  80. Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study
    Tagreed A. Mazi, Kamil Borkowski, John W. I. Newman, Oliver Fiehn, Christopher L. Bowlus, Souvik Sarkar, Karen E. Matsukuma, Mohamed R. Ali, Dorothy A. Kieffer, Yu‐Jui Yvonne Wan et al. · 2021 · Free Radical Biology and Medicine
  81. Branched-chain amino acids alter cellular redox to induce lipid oxidation and reduce de novo lipogenesis in the liver
    Chaitra Surugihalli, Vaishna Muralidaran, Caitlin E. Ryan, Kruti Patel, David Xiao-Ming Zhao, Nishanth E. Sunny · 2023 · American Journal of Physiology-Endocrinology and Metabolism
  82. Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
    Mathias Flensted-Jensen, Denise Oró, Emma A. Rørbeck, Chen Zhang, Martin Rønn Madsen, Andreas Nygaard Madsen, Jenny Norlin, Michael Feigh, Steen Larsen, Henrik H. Hansen · 2024 · BMC Gastroenterology
  83. ATGL promotes the proliferation of hepatocellular carcinoma cells via the p‐AKT signaling pathway
    Meiling Liu, Xuegao Yu, Li‐Ying Lin, Jiankai Deng, Kanglong Wang, Baochang Su, Yong Xia, Xiaohua Tang, Honghai Hong · 2019 · Journal of Biochemical and Molecular Toxicology
  84. Liver involvement in inflammatory bowel disease: What should the clinician know?
    Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, M. Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Maria Grazia Rendina · 2021 · World Journal of Hepatology
  85. Beyond M1/M2: The role of reactive oxygen species in liver fibrosis and immune modulation
    Lu, Huilun, Huang, Jie, Wang, Ya-chao, Casals, Eudald, Casals, Gregori, Zeng, Muling · 2025 · Redox Biology
  86. Cohabitation facilitates microbiome shifts that promote isoflavone transformation to ameliorate liver injury
    Yunong Zeng, Rong Wu, Yi He, Qian Zhang, Ze Wang, Ping Qin, Fangyuan Yang, Yingshi Han, Mingjing Hao, Yujian Zheng et al. · 2025 · Cell Host & Microbe
  87. Inflammatory liver diseases and susceptibility to sepsis
    Hong Lü · 2024 · Clinical Science
  88. Mitochondrial metabolism and calcium homeostasis in the development of NAFLD leading to hepatocellular carcinoma
    Snigdha Bhowmick, Vandana Singh, Sandipan Jash, Megha Lal, Soumya Sinha Roy · 2021 · Mitochondrion
  89. Determination of low levels of 2 H‐labeling using high‐resolution mass spectrometry: Application in studies of lipid flux and beyond
    Kithsiri B. Herath, Wendy Zhong, Jiong Yang, Ablatt Mahsut, Rory J. Rohm, Vinit Shah, Jose M. Castro‐Perez, Haihong Zhou, Athula B. Attygalle, Ling Kang et al. · 2013 · Rapid Communications in Mass Spectrometry
  90. Molecular classification of fatty liver by high‐throughput profiling of protein post‐translational modifications
    Yasuyo Urasaki, Ronald R. Fiscus, Thuc T. Le · 2016 · The Journal of Pathology
  91. Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways
    Moonju Hong, Jeeyoun Jung, Hee‐Sook Park, So Min Lee, Nam‐Joo Jeong, Soon-Hee Kim, Kyoung-Won Lee, Ju-A Lee, Myung‐Sunny Kim · 2017 · PLoS ONE
  92. The ins and outs of liver fat metabolism: The effect of phenotype and diet on risk of intrahepatic triglyceride accumulation
    Kieran Smith, Kaitlyn M.J.H. Dennis, Leanne Hodson · 2025 · Experimental Physiology
  93. Restoring metabolic flexibility: targeting organelle interaction networks in the pathogenesis and therapy of MASLD
    Yiming Liu, Yue Wang, Jiaying Zhou, Hong Li, Caiyun Liu, Beilei Zhong, Juan Liu, Leiming Liu, Lingling Zhang, Lei Sun · 2025 · Frontiers in Cell and Developmental Biology
  94. Basigin deficiency prevents anaplerosis and ameliorates insulin resistance and hepatosteatosis
    Akihiro Ryuge, Tomoki Kosugi, Kayaho Maeda, Ryoichi Banno, Yang Gou, Kei Zaitsu, Takanori Ito, Yuka Sato, Akiyoshi Hirayama, Shoma Tsubota et al. · 2021 · JCI Insight
  95. Endurance exercise-mediated metabolic reshuffle attenuates high-caloric diet-induced non-alcoholic fatty liver disease
    Joshua J. Cook, Madeline Wei, Benny Segovia-Ruiz, Ludmila Cosío-Lima, Jeffrey Simpson, Scott M. Taylor, Yunsuk Koh, Sangho Kim, Youngil Lee · 2022 · Annals of Hepatology
  96. Alterations in Cytoskeleton and Mitochondria in the Development and Reversal of Steatosis in Human Hepatocytes
    Letao Fan, Aslıhan Gökaltun, Sarah Maggipinto, Yoshinori Kitagawa, J. A. Jeevendra Martyn, Heidi Yeh, Basak E. Uygun, Martin L. Yarmush, Osman Berk Usta · 2023 · Cellular and Molecular Gastroenterology and Hepatology
  97. Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Waseem Amjad, IRINA Y. SHALAUROVA, Erwin Garcia, Eke G. Gruppen, Robin P. F. Dullaart, Alex M. DePaoli, Zhenghui Gordon Jiang, Michelle Lai, Margery A. Connelly · 2023 · International Journal of Molecular Sciences
  98. Pharmacological SERCA activation limits diet-induced steatohepatitis and restores liver metabolic function in mice
    Tomasz K. Bednarski, Mohsin Rahim, Clinton M. Hasenour, Deveena R. Banerjee, Irina A. Trenary, David H. Wasserman, Jamey D. Young · 2024 · Journal of Lipid Research
  99. Insights into the pathogenesis of gestational and hepatic diseases: the impact of ferroptosis
    Yilan You, Zhiwen Qian, Ying Jiang, Lingyan Chen, Danping Wu, Lu Liu, Feng Zhang, Xin Ning, Yan Zhang, Jianping Xiao · 2024 · Frontiers in Cell and Developmental Biology
  100. Insights on post-translational modifications in fatty liver and fibrosis progression
    C. Nageswara Raju, Kavitha Sankaranarayanan · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease